Reach Us +441414719275
Editor - Shekher Mohan | Marshall University | 22316

Journal of Neuroscience and Neuropharmacology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Shekher Mohan

Shekher Mohan
Shekher Mohan
Assistant Professor
Department of Pharmaceutical Science and Research
School of Pharmacy
Marshall University
Tel: 304-696-7371
Marshall University


Dr. Shekher Mohan has received his PhD in Oklahoma State University during the period of 2004-2008. Currently, he is working as an Assistant Professor in Marshall University. He is serving as an editorial member of several reputed journals like Frontiers in Neuropharmacology, Annals in Pharmacology & Pharmaceutics, EC Pharmacology & Toxicology, etc. He has authored 14 research articles/books.

Research Interest

Excitotoxicity; Heme; In Vitro; Immunology; Inflammation; Injury; Neurologic Deficit; Neuronal survival; Pharmacology; Pharmaceutical preparations; pre-clinical; Signal Transduction; Stroke; Therapeutic Effect; Therapeutic target; Toxic effect; Translational Research; Addiction; Opioids; Substance abuse




Morphine-Mediated Cytoprotection against Hemin in SK-N-SH and A172 Cells

Novel Drugs for Neurodisorders

Shekher Mohan, Tanner Robinson, Noah Allen, Lance Armstrong and Sarah Stevens
Research Article: Neurochem Neuropharm
DOI: 10.4172/2469-9780.1000113
Shekher Mohan*
Editor Note: Neurochem Neuropharm
DOI: 10.4172/2469-9780.1000e101